Covered recipient · General Payments record
TIJANA SKREPNIK
Allopathic & Osteopathic Physicians Radiology Radiation Oncology
General Payments · PY2019–2024
$871.81
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $196.15 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $93.29 | 4 |
| ARGENX US, INC. | $28.32 | 2 |
| ACADIA Pharmaceuticals Inc | $27.44 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $16.28 | 1 |
| Neurocrine BioSciences, Inc. | $15.42 | 1 |
| Mallinckrodt Hospital Products Inc. | $15.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $27.44 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147994106 | CMS |
| ARGENX US, INC. | $13.10 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142106197 | CMS |
| ARGENX US, INC. | $15.22 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142119201 | CMS |
| Mallinckrodt Hospital Products Inc. | $15.40 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145139459 | CMS |
| Neurocrine Biosciences, Inc. | $15.42 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150873776 | CMS |
| Novartis Pharmaceuticals Corporation | $16.28 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087344551 | CMS |
| UCB, Inc. | $27.87 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143254090 | CMS |
| UCB, Inc. | $25.27 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143254095 | CMS |
| UCB, Inc. | $20.22 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143254099 | CMS |
| UCB, Inc. | $19.93 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143254103 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.